Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®GlobeNewsWire • 12/19/25
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?The Motley Fool • 12/14/25
Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks24/7 Wall Street • 12/11/25
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to PlayZacks Investment Research • 12/09/25
Glenview Doubles Down on Teva Stock With $72 Million Buy, According to Recent SEC FilingThe Motley Fool • 12/09/25
Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in AdultsGlobeNewsWire • 12/09/25
Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 TranscriptSeeking Alpha • 12/04/25
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech StocksThe Motley Fool • 11/30/25
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®GlobeNewsWire • 11/25/25
This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He's Buying Now.24/7 Wall Street • 11/24/25
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference in DecemberGlobeNewsWire • 11/21/25
Teva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/18/25
Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines BusinessSeeking Alpha • 11/14/25
Billionaire Stanley Druckenmiller Sold His Fund's Entire Stakes in Nvidia and Palantir for a Scorching-Hot Drug Stock That's Up 218% Since Mid-2023The Motley Fool • 11/11/25
Teva Pharmaceutical Industries Limited (TEVA) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/10/25
Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?Zacks Investment Research • 11/10/25
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily LivingGlobeNewsWire • 11/07/25
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?Zacks Investment Research • 11/07/25
TEVA Q3 Earnings & Revenues Beat, Austedo Sales View Raised, Stock UpZacks Investment Research • 11/06/25